Treatment of orbital inflammation with rituximab in Wegener's granulomatosis

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Baslund, Bo ^a   Wiencke, Anne Katrine ^b   Rasmussen, Niels ^c   Faurschou, Mikkel ^a   Toft, Peter Bjerre ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

Orbital inflammation; Rituximab; Wegener's granulomatosis

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; DRUG EFFICACY; EPIPHORA; EYE PAIN; FEMALE; FOLLOW UP; GRANULOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; MALE; ORBIT INFLAMMATION; PHYSICAL EXAMINATION; PRESSURE SENSATION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DENMARK; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MALE; MIDDLE AGED; ORBITAL DISEASES; PHYSICAL EXAMINATION; RECOVERY OF FUNCTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VISUAL ACUITY; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 84863754041     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. JENNETTE JC, FALK RJ, ANDRASSY K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
2. HOFFMAN GS, KERR GS, LEAVITT RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
3. PAKROU N, SELVA D, LEIBOVITCH I Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 2006; 35: 284-92.
4. BIJLSMA WR, HRJ, MOURITS MP, KALMANN R Orbital mass as manifestation of Wegener's granulomatosis; an ophthalmologic diagnostic approach. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S35-9.
5. FECHNER FP, FAQUIN WC, PILCH BZ Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope 2002; 112: 1945-50.
6. STONE JH, MERKEL PA, SPIERA R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363: 221-32.
7. JONES RB, TERVAERT JW, HAUSER T et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363: 211-20.
8. TAYLOR SR, SALAMA AD, JOSHI L et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum 2009; 60: 1540-7.
9. ARIES PM, HELLMICH B, VOSWINKEL J et al. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 2006; 65: 853-8.
10. HELLMICH B Update on the management of systemic vasculitis: what did we learn in 2009? Clin Exp Rheumatol 2010; 28 (Suppl. 57): S98-103.
11. BUSSONE G, KASWIN G, DE MENTHON M et al. Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis. Clin Exp Rheumatol 2010; 28: 90-2.
12. LAMPRECHT P, CSERNOK E, GROSS WL Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis. J Intern Med 2006; 260: 187-91.
13. TALAR-WILLIAMS C, SNELLER MC, LANGFORD CA et al. Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis. Br J Ophthalmol 2005; 89: 493-7.